{'52WeekChange': 0.6152272,
 'SandP52WeekChange': None,
 'address1': '440 Stevens Avenue',
 'address2': 'Suite 200',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 0.675,
 'askSize': 1800,
 'averageDailyVolume10Day': 1591887,
 'averageVolume': 1677784,
 'averageVolume10days': 1591887,
 'beta': 1.1014,
 'beta3Year': None,
 'bid': 0.6701,
 'bidSize': 1000,
 'bookValue': 0.204,
 'category': None,
 'circulatingSupply': None,
 'city': 'Solana Beach',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 0.71,
 'dayLow': 0.6301,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -3.879,
 'enterpriseToRevenue': 27.388,
 'enterpriseValue': 60144036,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 0.6062857,
 'fiftyTwoWeekHigh': 0.93,
 'fiftyTwoWeekLow': 0.19,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 121313279,
 'forwardEps': -0.21,
 'forwardPE': -3.1914287,
 'fromCurrency': None,
 'fullTimeEmployees': 6,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.00317,
 'heldPercentInstitutions': 0.38104,
 'industry': 'Diagnostics & Research',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1585612800,
 'lastMarket': None,
 'lastSplitDate': 1328054400,
 'lastSplitFactor': '10:1',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/organovo.com',
 'longBusinessSummary': 'Organovo Holdings, Inc., a biotechnology company, '
                        'develops bioprinted human tissues based on its 3D '
                        'human tissue platform technology that emulate human '
                        'biology and diseases. Its 3D human tissue platform '
                        'includes its proprietary NovoGen Bioprinters, which '
                        'are automated devices that enable the fabrication of '
                        '3D living tissues comprised mammalian cells; and '
                        'related technologies for preparing bio-inks and '
                        'bioprinting multicellular tissues with complex '
                        'architecture. The company offers ExVive human liver '
                        'tissue and ExVive human kidney tissue used for '
                        'predictive preclinical testing of drug compounds. It '
                        'is also developing in vivo liver tissues to treat '
                        'end-stage liver, life-threatening, and orphan '
                        'diseases; and NovoTissues liver product using cells '
                        'from a liver donor and cells from an umbilical cord '
                        'donor. The company was founded in 2007 and is '
                        'headquartered in Solana Beach, California.',
 'longName': 'Organovo Holdings, Inc.',
 'market': 'us_market',
 'marketCap': 87499968,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_106718277',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -18710000,
 'nextFiscalYearEnd': 1648684800,
 'open': 0.71,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '858 224 1000',
 'previousClose': 0.7107,
 'priceHint': 4,
 'priceToBook': 3.285294,
 'priceToSalesTrailing12Months': 39.845158,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 0.71,
 'regularMarketDayLow': 0.6301,
 'regularMarketOpen': 0.71,
 'regularMarketPreviousClose': 0.7107,
 'regularMarketPrice': 0.71,
 'regularMarketVolume': 1064529,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 130558000,
 'sharesPercentSharesOut': 0.0094,
 'sharesShort': 1228245,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 1580980,
 'shortName': 'Organovo Holdings, Inc.',
 'shortPercentOfFloat': 0.011,
 'shortRatio': 1.16,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'ONVO',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.144,
 'twoHundredDayAverage': 0.45070922,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '6bb0bfc5-56ab-33b9-b78e-ae29aa8a0044',
 'volume': 1064529,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.organovo.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '92075'}